Clinical outcome of recurrent giant cell tumor of the extremity in the era before molecular target therapy: the Japanese Musculoskeletal Oncology Group study

BACKGROUND: Giant cell tumor of the bone (GCTB) is classified as an intermediate, locally aggressive but rarely metastasizing tumor. The mainstay of treatment for the treatment of GCTB had been the surgical removal until an anti- receptor activator of nuclear factor-kappa B ligands (RANKL) antibody...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:BMC Musculoskelet Disord
Hoofdauteurs: Takeuchi, Akihiko, Tsuchiya, Hiroyuki, Ishii, Takeshi, Nishida, Yoshihiro, Abe, Satoshi, Matsumine, Akihiko, Kawai, Akira, Yoshimura, Kenichi, Ueda, Takafumi
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: BioMed Central 2016
Onderwerpen:
Research Article
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4957292/
https://ncbi.nlm.nih.gov/pubmed/27448567
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12891-016-1163-z
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items